VORSCHAU

PRESSETERMINE

AKTUELLES PRESSEFOTO

IR Nachrichten


WETTER
Graz: bedeckt
24°
Innsbruck: Regen
22°
Linz: Regen
22°
Wien: bedeckt
20°
© wetter.net

Stadtname / PLZ

AKTIENKURSE
 
ADHOC
Do, 19.12.2024 13:00
Meldung drucken Artikel weiterleiten
pta20241219021
Public disclosure of inside information according to article 17 MAR
Pressefach Pressefach

Darwin AG: Darwin AG acquires all shares in MEDICOPHARM AG

Munich, 19/12/2024 (pta021/19.12.2024/13:00) - Darwin AG (ISIN DE000A3C35W0) has acquired all shares in MEDICOPHARM AG Arzneimittel und Medikal Produkte (hereinafter "Medicopharm"), based in Nußdorf am Inn, with a purchase agreement dated today. Medicopharm is active in the manufacture and distribution of pharmaceuticals and thus complements Darwin AG's existing portfolio in this sector.

According to the management board of Darwin AG, the acquisition will have a significant impact on the group's earnings situation. The parties have agreed not to disclose the economic details of the transaction.

Background

The "Darwin Group" (i.e. Darwin AG including its subsidiaries), headquartered in Munich (Germany), is a European biotechnology company, particularly in the field of human genetics. The genetic analysis carried out in our own laboratory are used in diagnostics, therapy and prevention of diseases as well as in the production of individually designed nutritional supplements and cosmetics. Darwin also acts as a partner for doctors, therapists, pharmacists, nutritionists or fitness trainers and, by analyzing the respective genetic predisposition of the patient or customer, helps to ensure the best possible treatment or care for their needs. Darwin also invests in innovative companies in the biotech, healthcare and life sciences sectors.

(Ende)

Aussender: Darwin AG
Brienner Straße 7
80333 München
Deutschland
Ansprechpartner: Daniel Wallerstorfer
Tel.: +49 89 20 500 450
E-Mail:
Website: www.darwin-biotech.com
ISIN(s): DE000A3C35W0 (share)
Börsen: open market (free market) in Frankfurt, m:access in Munich
Darwin AG
   
Wie fanden Sie diese Meldung?
Weitersagen
likes dislike Share Share |
Social Media
ETARGET

FOCUSTHEMA


SPECIALS


Werbung
middleAdvertising